DARE Dare Bioscience Inc. Earnings per share for the last twelve months

Official company branding of Daré Bioscience, Inc. (DARE)

Dare Bioscience, Inc. (DARE) develops advanced therapeutic solutions for women. The rolling annual earnings per share value demonstrates capital management efficiency, where the -0.80 metric reflects the current figure. Dare Bioscience, Inc. (DARE) is developing partnerships with global pharma behemoths for joint research. The strategy relies on expanding the product portfolio and B2B licensing. Operations are conducted within a stable US legal framework without geopolitical risks.

DARE (Dare Bioscience, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/12/2026

Financial and market metric breakdowns for Dare Bioscience (DARE)

- current quotes and average value forecast:
Price Chart Dare Bioscience, Inc.|DARE - Average Forecast Price
- market capitalization data:
Market Value Dare Bioscience|DARE - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Daré Bioscience|DARE - Total Stockholders' Equity|Market Value to Book Value Ratio darebioscience.com|DARE - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Dare Bioscience Inc.|DARE - Company Aggregate Debts|Debt to Book Capitalization Ratio Dare Bioscience|DARE - Company Long-Term Loans and Borrowings|Company Short-Term Debts Daré Bioscience|Quick Liquidity Indicator darebioscience.com
- net income and valuation multiples indicators:
DARE - Final Profit|Projected Future Earnings Dare Bioscience, Inc.|DARE - Price to Earnings Ratio|Forward P/E Multiple Daré Bioscience|DARE - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dare Bioscience|DARE - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Daré Bioscience|DARE - Net earnings per share for the last four quarters|Quarterly EPS earnings growth darebioscience.com|DARE - Net earnings per share growth this year|Earnings growth forecast for next year Dare Bioscience, Inc.
Analysis of all company metrics:DARE - Dare Bioscience, Inc.
Manufactured products of Dare Bioscience

Operational business resilience is determined by the ability to generate real income per share of capital. This indicator is calculated as the ratio of net income over a rolling year to the total number of shares, measuring the actual efficiency of resource allocation. For Dare Bioscience, Inc. (DARE), this parameter reflects the financial transition from R&D expenditures to profits from gel sales. The dynamics of commercial scaling through global partners directly impact the TTM net income per share metric. Analysis of this chart allows for an assessment of the company's pace toward reaching the break-even point.

Competing companies

OGN - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months TherapeuticsMD, Inc.|Palatin Technologies, Inc. (PTN) - Earnings per share for the last twelve months